A combination efficacy study in Africa of two DNA-MVA- or DNA- Env protein HIV-1 vaccine regimens with pre-exposure prophylaxis (PrEP) – supplementary funding for MPLA-Liposomes

£1.26M GBP

Funder	Medical Research Council
Recipient Organization	Imperial College London
Country	United Kingdom
Start Date	Mar 16, 2021
End Date	Mar 30, 2021
Duration	14 days
Number of Grantees	2
Roles	Principal Investigator; Award Holder
Data Source	UKRI Gateway to Research
Grant ID	`MC_PC_20056`

Grant Description

Abstracts are not currently available in GtR for all funded research.

This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.